Impact of antithrombin III on hepatic and intestinal microcirculation in experimental liver cirrhosis and bowel inflammation: An in vivo analysis

Table 2 Microcirculatory parameters of the liver, mesentery and ileal mucosa (mean±SD)

	Cirrhosis	Cirrhosis and IBD	ATIII treatment group (cirrhosis and IBD)	Controls
Vessel diameter (µm)
Liver	27.86±2.03a	28.15±1.72	28.08±1.27	23.03±0.62
Mesentery	32.06±8.91	33.51±5.16	42.51±7.04e	33.46±11.66
Mucosa	7.51± 0.30	6.32±0.41	7.21±0.52	7.20±0.23
RBC velocity (mm/s)
Liver	0.93±0.09a	1.08±0.13c	1.16±0.11	1.22±0.18
Mesentery	2.81±0.49	3.28±0.42	2.93±0.41	3.11±0.35
Mucosa	2.03±0.15	1.81±0.13c	2.11±0.12	2.18±0.16
Volumetric blood flow (nL/min)
Liver	32.1±0.43	39.5±0.43c	40.9±0.62	31.2±0.6
Mesentery	135.1±3.56a	149.8±2.41c	243.1±3.71e	156.5±4.3
Mucosa	5.3±0.31	3.49±0.6c	5.13±0.4e	5.4±0.25

^aP<0.05 cirrhosis vs controls;

^cP<0.05 cirrhosis+IBD vs cirrhosis;

^eP<0.05 ATIII vs cirrhosis+IBD.